KLHL6: a proteostatic guardian against T-cell exhaustion

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• T-cell exhaustion is a major hurdle in cancer immunotherapy.
• The precise molecular mechanisms underlying T-cell exhaustion are not fully understood.
• Proteostasis, the maintenance of protein homeostasis, is critical for cellular function.

Purpose of the Study:

• To identify novel regulators of proteostasis in T cells.
• To investigate the role of Cullin3-RING E3 ubiquitin ligase complexes (CRL3) adaptor proteins in T-cell function.
• To explore KLHL6 as a potential therapeutic target for T-cell exhaustion.

Main Methods:

• Utilized proteomic and genetic approaches in T cells.
• Investigated the interaction between KLHL6 and its substrates.
• Analyzed the impact of KLHL6 downregulation on T-cell function and proteostasis.
• Examined KLHL6 expression in T-cell exhaustion models.

Main Results:

• Identified Kelch-like protein 6 (KLHL6) as a key proteostasis regulator in T cells.
• Demonstrated that KLHL6 downregulation in chronically stimulated T cells leads to the accumulation of specific proteins (high mobility group box protein and phosphoglycerate mutase family member 5).
• Showed that this accumulation drives T-cell dysfunction and exhaustion.

Conclusions:

• T-cell exhaustion can be viewed as a proteostatic disorder.
• KLHL6 plays a critical role in maintaining T-cell function by regulating protein homeostasis.
• KLHL6 represents a promising therapeutic target for enhancing anti-cancer immunity.